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Summary: It is well established that accumulation of methylmalonic acid may provide an early clue to the
existence of tissue cobalamin (vitamin B12) deficiency. To verify whether methylmalonic acid accumulates in
adult heterozygotes for inherited methylmalonic-acidaemia and thereby gives "false" positive test results for
cobalamin deficiency, we measured the concentration of methylmalonic acid in serum and its urinary excretion
in six parents of three children with severe methylmalonic-acidaemia. We found levels of methylmalonic acid
similar to those in normal subjects. In serum, the concentrations of methylmalonic acid ranged from 0.12 to
0.39 μπιοΐ/ΐ (reference range: 0.05 — 0.44 μηιοΐ/ΐ). In urine, the values ranged from 1.18 to 2.48 mmol per mol
of creatinine (reference range: 0.58 — 3.56). We conclude that the 2% of carriers of inherited methylmalonic-
acidaemia in the general population do not invalidate the usefulness of measurement of methylmalonic acid
in serum or urine for the clinical evaluation of cobalamin deficiency.
Introduction
Determination of methylmalonic acid in serum or
urine for evaluating cobalamin deficiency has recently
aroused interest in clinical chemistry, especially as an
important diagnostic procedure in patients with neu-
rologic disorders with few or no haematological ab-
normalities, or normal or only slightly depressed
serum cobalamin concentrations (1 — 3). L(R)-meth-
ylmalonyl-CoA is a normal intermediate in the bio-
chemical pathway from propionyl-CoA to succinyl-
CoA. Precursors of propionyl-CoA include isoleucine,
valine, threonine, methionine, cholesterol, and odd-
carbon-number fatty acids. In children with inherited
disorders of cobalamin metabolism or enzyme defects
in the complex, metabolic conversion of methylma-
lonic acid (the various inherited methylmalonic aci-
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daemias), methylmalonic acid is found in serum and
urine in large quantities. In adults, methylmalonic
acid accumulates when the conversion of L(R)-meth-
ylmalonyl-CoA to succinyl-CoA by methylmalonyl-
CoA mutase2), mediated by 5'-deoxyadenosylcoba-
lamin, becomes impaired due to aquired cobalamin
deficiency. An increased concentration of methylma-
lonic acid in serum and its excessive urinary excretion
are believed to be direct measures of tissue stores of
cobalamin (4) and thus provide the first indication of
functional cobalamin deficiency (3, 5).
Recently, Lindenbaum et al. (3) reported that among
30 patients with neuropsychiatric disorders with no
haematological abnormalities, and with initial eleva-
tions of serum methylmalonic acid, the level fell mark-
2) Methylmalonyl-CoA
5.4.99.2
mutase (formerly isomerase) EC
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edly in all but 2 after treatment with cobalamin. This
finding prompted us to examine the possibility that
such subjects could be carriers of methylmalonic-
acidaemia (6). The combined incidence of these au-
tosomal recessive disorders is about one per 10000
live births. This means that the frequency of hetero-
zygotes for these traits in the normal population is
approximately 2%. However, there are no data for
serum methylmalonic acid in the heterozygotes.
We undertook the present study to explore the pos-
sibility that methylmalonic acid accumulates in het-
erozygotes for methylmalonic-acidaemia, thereby in-
validating the usefulness of the determination of
methylmalonic acid in serum or urine for the clinical
evaluation of cobalamin deficiency.
Tab. 1. Concentrations in serum and urinary excretion of meth-
ylmalonic acid in six heterozygotes, parents of 3 chil-










































Freshly collected random urine samples and serum specimens
were obtained from six parents, aged 38 to 45 years, of three
children with severe methylmalonic-acidaemia (63.4—287
μηιοΐ/ΐ) and stored at — 20 °C until they could be analysed.
Methylmalonic acid in serum and urine was assayed using
stable-isotope-dilution with solid-phase extraction of the sam-
ples; the dicyclohexyl derivatives were determined by a gas
chromatographic-mass spectrometric procedure with the mass
spectrometer in the selected-ion monitoring mode, as previously
described in detail (7). All specimens were assayed in duplicate.
Between-day imprecision of the method, determined twice dur-
ing routine analyses for 20 days, is 0.025 μηιοΐ/ΐ (SD) at a
concentration in serum of 0.32 μπιοΐ/ΐ (CV = 7.9%). For urine,
the between-day imprecision is 0.08 at a concentration of 1.20
mmol per mol of creatinine (CV = 6.7%). The concentration
of methylmalonic acid in urine specimens from 20 healthy, adult
hospital personnel, aged 22 — 56 years, ranged from 0.58 to 3.56
mmol per mol of creatinine (mean = 1.68). No age- or sex-
related differences were apparent (7). In 58 throughly investi-
gated non-cobalamin-deficient healthy subjects, aged 40 — 68
years, we most recently found a range of 0.05 — 0.44 μηιοΐ/ΐ
(mean = 0.21, SD = 0.094). Α χ2 goodness-of-flt test did not
prove any deviation from the normal distribution (0.90 > Ρ
> 0.80), and no age- or sex-related differences could be dem-
onstrated (data to be published elsewhere).
Creatinine was determined by the Technicon automated alkaline
picrate method (8). Serum cobalamin concentrations were as-
sayed using a RIA method utilizing hog intrinsic factor (9).
Results
As shown in table 1, in heterozygosity for methyl-
malonic-acidaemia, the concentrations of methylma-
lonic acid were similar to those in normal subjects.
In serum, concentrations of methylmalonic acid
ranged from 0.12 to 0.39 μηιοΐ/ΐ (mean = 0.23). In
urine, the values ranges from 1.18 to 2.48 mmol per
mol of creatinine (mean = 1.79). As expected, serum
cobalamin concentrations were normal (390 — 770
pmol/1; reference range: 200 — 800 pmol/1).
Discussion
Acquired cobalamin deficiency is a continuum with
anaemia and macrocytosis only in the final stage (10).
Currently, serum cobalamin is essentially the only
diagnostic parameter in clinical chemistry generally
available for determining whether a patient is coba-
lamin deficient. It is therefore still widely used, both
for clinical and research purposes, as in index of tissue
cobalamin deficiency. However, serum cobalamin
does not necessarily reflect the cobalamin status of
the body. In cobalamin deficiency, serum cobalamin
levels may be normal or high, and furthermore, low
levels of cobalamin in serum do not prove deficiency.
The limitations in using only the serum cobalamin
concentration to detect cobalamin deficiency are
widely recognized (11 — 14), the need for an ancillary
diagnostic test in patients with low or low-normal
serum cobalamin has been emphasized, and testing
for methylmalonic acid has been recommended (1—3,
15 — 18). Because of the considerably higher concen-
trations of methylmalonic acid in urine as compared
with serum, most studies have dealt with its measure-
ment in the former. However, patients with early
evidence of cobalamin deficiency may be best differ-
entiated from normal subjects by measurement of
serum methylmalonic acid (19).
Now that the analysis of serum methylmalonic acid
is becoming increasingly used in clinical laboratories,
it is necessary to study the effect of various patholog-
ical conditions. As mentioned, methylmalonic acid
accumulates in at least two conditions, i. e. in patients
with acquired cobalamin deficiency, and in children
with inherited abnormalities in the metabolic pathway
for methylmalonic acid. The relevant metabolites ac-
cumulate in heterozygotes for some inherited disor-
ders. The present study, however, gives no evidence
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of impaired methylmalonic acid metabolism in hetero-
zygotes for methylmalonic-acidaemia. Therefore, the
2% of heterozygotes in the general population do not
invalidate the usefulness of the measurement of meth-
ylmalonic acid in serum or urine. Our results further
show that normal levels of methylmalonic acid do not
exclude the heterozygous state, and determination of
serum methylmalonic acid is not a tool for detection
of carriers in families with a history of methylmalonic-
acidaemia.
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